Moreover, it has been found that IPF with mutations in TERT, RTEL1, or PARN has a significantly higher risk of death and chronic lung allograft dysfunction compared to those in patients without these mutations (79, 80). Here, RTEL1 is linked to chronic lung allograft dysfunction.